SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K

                 CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


         DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): February 6, 2001


                          BIOSHIELD TECHNOLOGIES, INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)


            GEORGIA                       0-24913              58-2181628
- -------------------------------------------------------------------------------
(STATE OR OTHER JURISDICTION OF   (COMMISSION FILE NUMBER)  (I.R.S. EMPLOYER
 INCORPORATION OR ORGANIZATION)                             IDENTIFICATION NO.)



4405 International Blvd.
NORCROSS, GEORGIA                                                 30093

REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE:           (770)925-3653



          (FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)

ITEM 5.       Other Events.
              ------------

               Dr. Kevin Smith,  Chief  Medical  Officer,  has been named to the
               Board of Directors for BioShield Technologies,  Inc. on March 27,
               2001. Dr. Smith is a practicing physician,  and has held a number
               of positions in the field of occupational  health and safety. Dr.
               Smith  grew his  practice  to  become  the  largest  provider  of
               occupational  health in the state of Iowa and  eventually  merged
               that practice into Concentra.  In addition, Dr. Smith started and
               acquired  several   occupational   health  practices,   which  he
               eventually sold to  HealthSouth.  Dr. Smith is Board Certified in
               the field of  occupational  health.  Dr. Smith has also served on
               the  faculty  of Yale,  Drake and  Emory  University.  Dr.  Smith
               received his M.D. from the Universidad Central del Este School of
               Medicine in San Pedro de Marcoris, Dominican Republic.


                                               SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                           BIOSHIELD TECHNOLOGIES, INC.
                                           (Registrant)


Date: March 27, 2001                       /s/ Timothy C. Moses


                                           TIMOTHY C. MOSES
                                           President and Chief Executive Officer